By Chris Hutching
Friday 27th October 2000
|Text too small?|
C G Surgical's 10 million shares were issued at 8c recently and Southern Capital bought one million of them. A few early trades last week saw the shares change hands at 60c but this week a parcel of 5000 shares was traded at $1.70.
South Island businessman Mr Paterson, who is a founder shareholder and director of Southern Capital, identified the opportunity to invest in C G Surgical through his links with Otago University researchers.
Other recent fledgling bio-tech companies where Southern Capital has stakes include Blis, which owns patents over a cure for throat infections, and A2 Corporation, which claims patents over milk proteins that may have significance for some health conditions. After initial stagging on Blis and A2 shares issued at 10c, trades have settled to a narrower range around 80c and $2.30, still representing considerable paper profits for Southern Capital.
Managing director Graeme Wong said Southern Capital was retaining its stakes for now.
C G Surgical was developed by engineer Richard Cathro. It has patents over a titanium and teflon clip which prevents pressure on the spinal cord. Pressure can cause neurological-related complaints.
No comments yet
Seeka hikes interim dividend as first-half profit almost doubles
Tough second-half hurts NZ Post and Kiwibank full-year earnings
Delegat to pay bigger dividend after posting record annual operating profit
NZME posts 0.5% gain in debut first-half earnings as costs fell faster than revenue
CBL first-half profit falls 19% currency losses offset growth in premiums
Air NZ rides the tourism boom with record full-year earnings
Vista first-half profit more than doubles as acquisitions lift revenue 49%
FIRST CUT: Sky TV FY earnings down 15%, citing merger costs and content 'arms race'
FIRST CUT: Air NZ delivers bumper pre-tax profit for 2016 FY of $663 mln
Living Cell Technologies considers 'medical tourism' if Parkinson's therapy trial succeeds